Table 2. Summary of Kaplan-Meier analysis of early-phase circulating miRNAs in predicting overall and disease-free survivals of HCC patients after liver transplantation.
miRNAs | Kaplan-Meier analysis of Overall survival | Kaplan-Meier analysis of Disease-free survival | ||
---|---|---|---|---|
Log-Rank value | P value | Log-Rank value | P value | |
Let7C | 0.606 | 0.436 | 0.646 | 0.422 |
miR-21 | 0.297 | 0.586 | 0.395 | 0.530 |
miR-23b | 1.571 | 0.210 | 1.502 | 0.220 |
miR-27b | 3.448 | 0.063 | 3.518 | 0.061 |
miR-122 | 6.505 | 0.011* | 6.984 | 0.008** |
miR-125b | 1.757 | 0.185 | 2.021 | 0.155 |
miR-148a | 4.530 | 0.033* | 4.862 | 0.027* |
miR-151p-5p | 2.025 | 0.155 | 2.012 | 0.156 |
miR-192 | 5.301 | 0.021* | 5.310 | 0.021* |
miR-195 | 0.381 | 0.537 | 0.452 | 0.502 |
miR-199a-3p | 0.008 | 0.927 | 0.063 | 0.802 |
miR-215 | 3.838 | 0.050* | 4.440 | 0.035* |
miR-1246 | 12.446 | 0.000*** | 12.293 | 0.000*** |
miR-1290 | 6.201 | 0.013* | 6.498 | 0.011* |
p<0.05;
p<0.01;
P<0.001.